688301.SH
iRay Technology Co., Ltd.
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 77.90
+1.33%Year over year
Reported trailing growth
- Revenue
- +34.8%
- EBITDA
- —
- EBIT
- +42.4%
- EPS
- +43.4%
- Free cash flow
- -18.8%
- Operating cash flow
- +174.8%
Forward estimates
Based on analyst estimates
- Revenue
- -59.0%
- EBITDA
- -28.6%
- EPS
- -70.8%
Three-year CAGR
- Revenue
- +13.3%
- EBITDA
- +5.6%
- EBIT
- -1.2%
- Net income
- +0.5%
- EPS
- -20.3%
- Free cash flow
- +64.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026